MA42317B2 - Composition de vaccin combinée pour administration multiple - Google Patents
Composition de vaccin combinée pour administration multipleInfo
- Publication number
- MA42317B2 MA42317B2 MA42317A MA42317A MA42317B2 MA 42317 B2 MA42317 B2 MA 42317B2 MA 42317 A MA42317 A MA 42317A MA 42317 A MA42317 A MA 42317A MA 42317 B2 MA42317 B2 MA 42317B2
- Authority
- MA
- Morocco
- Prior art keywords
- vaccine
- combination vaccine
- vaccine composition
- multiple administration
- immunogenic composition
- Prior art date
Links
- 229940001442 combination vaccine Drugs 0.000 title abstract 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 241000274177 Juniperus sabina Species 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 229940030156 cell vaccine Drugs 0.000 abstract 1
- 229940029583 inactivated polio vaccine Drugs 0.000 abstract 1
- 229940066827 pertussis vaccine Drugs 0.000 abstract 1
- 229960005323 phenoxyethanol Drugs 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
- A61K31/115—Formaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0017—Combination vaccines based on whole cell diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention concerne une composition immunogène à doses multiples pour un vaccin combiné multivalent, dans laquelle (i) le vaccin combiné multivalent contient un vaccin contre la coqueluche vaccin à cellules entières (wp) ou un vaccin contre la coqueluche acellulaire(ap), et un vaccin contre la polio inactivé sabin (sipv) ; et (ii) la composition contient du 2-phénoxyéthanol (2-pe) et du formaldéhyde (hcho) en tant que conservateurs ; et un procédé de préparation d'une composition immunogène à d
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150131157 | 2015-09-16 | ||
PCT/KR2016/010313 WO2017048038A1 (fr) | 2015-09-16 | 2016-09-13 | Composition de vaccin combinée pour administration multiple |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42317B2 true MA42317B2 (fr) | 2021-11-30 |
Family
ID=58289554
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42317A MA42317B2 (fr) | 2015-09-16 | 2016-09-13 | Composition de vaccin combinée pour administration multiple |
MA52400A MA52400B1 (fr) | 2015-09-16 | 2016-09-13 | Composition de vaccin combinée pour administration multiple |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA52400A MA52400B1 (fr) | 2015-09-16 | 2016-09-13 | Composition de vaccin combinée pour administration multiple |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR101864029B1 (fr) |
BR (1) | BR112018005291A2 (fr) |
EA (1) | EA037283B1 (fr) |
MA (2) | MA42317B2 (fr) |
PH (1) | PH12018500570A1 (fr) |
TN (1) | TN2018000063A1 (fr) |
WO (1) | WO2017048038A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110520154B (zh) * | 2017-03-15 | 2023-08-04 | 株式会社Lg化学 | 多价肺炎链球菌疫苗组合物 |
CN111032078A (zh) * | 2017-07-18 | 2020-04-17 | 血清研究所印度私人有限公司 | 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法 |
JOP20190242A1 (ar) * | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
WO2021176409A1 (fr) | 2020-03-05 | 2021-09-10 | Sanofi Healthcare India Private Limited | Combinaison de conservateurs pour composition de vaccin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920009729B1 (ko) * | 1990-08-29 | 1992-10-22 | 주식회사 녹십자 | 백일해, 디프테리아, 파상풍 및 b형 간염의 동시 예방을 위한 혼합백신 |
KR920009729A (ko) * | 1990-11-26 | 1992-06-25 | 전금자 | 원적외선이 발생하는 도자기 제조방법 |
UA40596C2 (uk) * | 1992-05-23 | 2001-08-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини та спосіб її одержання |
WO2009047434A2 (fr) * | 2007-09-12 | 2009-04-16 | Galderma Research & Development | Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant |
PE20100365A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion |
KR20140026392A (ko) * | 2011-03-02 | 2014-03-05 | 노파르티스 아게 | 저용량의 항원 및/또는 보조제를 갖는 조합 백신 |
-
2016
- 2016-09-13 MA MA42317A patent/MA42317B2/fr unknown
- 2016-09-13 KR KR1020160118261A patent/KR101864029B1/ko active IP Right Grant
- 2016-09-13 EA EA201890502A patent/EA037283B1/ru unknown
- 2016-09-13 MA MA52400A patent/MA52400B1/fr unknown
- 2016-09-13 BR BR112018005291A patent/BR112018005291A2/pt active Search and Examination
- 2016-09-13 WO PCT/KR2016/010313 patent/WO2017048038A1/fr active Application Filing
- 2016-09-13 TN TNP/2018/000063A patent/TN2018000063A1/en unknown
-
2018
- 2018-03-15 PH PH12018500570A patent/PH12018500570A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR101864029B1 (ko) | 2018-06-01 |
WO2017048038A1 (fr) | 2017-03-23 |
KR20170033254A (ko) | 2017-03-24 |
TN2018000063A1 (en) | 2019-07-08 |
MA52400A1 (fr) | 2022-06-30 |
PH12018500570A1 (en) | 2018-09-17 |
EA037283B1 (ru) | 2021-03-04 |
BR112018005291A2 (pt) | 2018-10-09 |
MA52400B1 (fr) | 2023-01-31 |
EA201890502A1 (ru) | 2018-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018013387A2 (pt) | vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit | |
MA42317B2 (fr) | Composition de vaccin combinée pour administration multiple | |
BR112018008102A2 (pt) | vacina de vírus sincicial respiratório | |
CR20150454A (es) | Compuestos amida para el tratamiento de vih | |
BR112018008078A2 (pt) | vacina de vírus influenza de amplo espectro | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
BR112017020837A2 (pt) | compostos de carbamoilpiridona policíclicos e seu uso farmacêutico | |
GB201101665D0 (en) | Immunogenic compositions | |
AR108829A1 (es) | Vacuna contra virus de bronquitis infecciosa | |
CL2016003048A1 (es) | Analogos de panonina minimas sintesis y uso de los mismos. | |
MX349119B (es) | Vacuna de virus de dengue inactivado. | |
BR112016026721A2 (pt) | vacinas com base em vesículas do tipo vírus (vlvs) para prevenir ou tratar infecção por vírus da hepatite b (hbv) crônica | |
BR112013017171A2 (pt) | vacina de combinação imunogênica estável, processo de preparação de vacina de combinação estável, método de uso de moléculas antigênicas e método de administração a indivíduos humanos | |
BR112015021523A2 (pt) | composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa | |
EA202190778A1 (ru) | Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения | |
BR112019003992A2 (pt) | vacina contra neisseria meningitidis | |
PE20151588A1 (es) | Vacuna contra el virus del dengue | |
CL2015001329A1 (es) | Composición para tratamiento por inmersion de raices de plantas. | |
BR112017006085A2 (pt) | compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila e uso como moduladores sgrm | |
UA116697C2 (uk) | Композиція для запобігання зараженню видами роду mycoplasma | |
CO2018013828A2 (es) | Composiciones farmacéuticas de oligómero de morfolino fósforodiamidato | |
MX2017006744A (es) | Composiciones adyuvantes y metodos relacionados. | |
MX2017016858A (es) | Composiciones inmunogenicas. | |
BR112018007673A2 (pt) | ?análogos de epotilona, métodos de síntese, métodos de tratamento e conjugados de fármaco dos mesmos? | |
AR117191A1 (es) | Composiciones inmunogénicas |